According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...

The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help ...

Call it a comfort food in more ways than one—and the chilly season is the perfect time to incorporate more of it into your ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease. | ...

Semaglutide, a drug used for diabetes and weight loss, might help reduce opioid overdoses in people with OUD and T2D.

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...